CtBP2 Overexpression in Neoadjuvantly Treated Breast Cancer by Immunohistochemistry and Its Relation to Clinical Outcomes

被引：0
|
作者：
Gayhart, Matthew [1 ]
McCoy, Kelly [2 ]
Cartagena, Lorraine Colon [3 ]
Idowu, Michael [4 ]
机构：
[1] VCU Sch Med, Richmond, VA USA
[2] Virginia Commonwealth Sch Med, Richmond, VA USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
154
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinical Outcomes of Breast Cancer Brain Metastases Treated with Stereotactic Radiation and Capecitabine
    Mills, M. N.
    Naz, A.
    Thawani, C.
    Walker, C.
    Figura, N. B.
    Forsyth, P.
    Etame, A. B.
    Liu, J. K.
    Vogelbaum, M. A.
    Yu, M.
    Robinson, T. J.
    Soliman, H.
    Han, H. S.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E685 - E686
  • [22] Identification of triple negative breast cancer (TNBC) subtypes by an immunohistochemistry (IHC) panel with impact on clinical outcomes
    Walsh, Elaine M.
    Shalaby, Aliaa
    Murillo, Laura
    Webber, Mark
    Kerin, Michael
    Glynn, Sharon
    Callaghy, Grace
    Ingoldsby, Helen
    Keane, Maccon
    CANCER RESEARCH, 2015, 75
  • [23] Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center
    Weiss, Jennifer A.
    Nicklawsky, Andrew
    Kagihara, Jodi A.
    Gao, Dexiang
    Fisher, Christine
    Elias, Anthony
    Borges, Virginia F.
    Kabos, Peter
    Davis, Sarah L.
    Leong, Stephen
    Eckhardt, Sue Gail
    Diamond, Jennifer R.
    CANCER MEDICINE, 2020, 9 (23): : 8801 - 8808
  • [24] HER 2 protein overexpression and gene amplification in breast cancer:: A comparison of immunohistochemistry and fluorescent and chromogenic in situ hybridization
    Sáez, A
    Andreu, F
    Fernández, S
    Seguí, M
    Rey, M
    LABORATORY INVESTIGATION, 2005, 85 : 49A - 49A
  • [25] Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer
    Lateef, Fouzia
    Jamal, Saba
    Nasir, Surrayya
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (08): : 581 - 585
  • [26] HER 2 protein overexpression and gene amplification in breast cancer:: A comparison of immunohistochemistry and fluorescent and chromogenic in situ hybridization
    Sáez, A
    Andreu, FJ
    Fernández, S
    Seguí, MA
    Rey, M
    MODERN PATHOLOGY, 2005, 18 : 49A - 49A
  • [27] Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy
    Li, BDL
    Brown, WA
    Ampil, FL
    Burton, GV
    Yu, H
    McDonald, JC
    ANNALS OF SURGERY, 2000, 231 (06) : 883 - 888
  • [28] Evaluation of MACC1 expression by immunohistochemistry in breast cancer and its relationship with clinical and pathological parameters
    Felezi, S.
    Naghshvar, F.
    Torabizadeh, Z.
    Jafarshad, J.
    HISTOPATHOLOGY, 2022, 81 : 28 - 28
  • [29] Clinical significance of HER2 overexpression as assessed by immunohistochemistry and fluorescence in situ hybridisation in patients with gastric cancer
    Im, S.
    Kim, J.
    Kim, M.
    Jordan, B.
    Oh, D.
    Lee, H.
    Yang, H.
    Kim, V
    Kim, W.
    Bang, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 20 - 21
  • [30] Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications
    Tan, Aihua
    Dang, Yiwu
    Chen, Gang
    Mo, Zengnan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 13405 - 13410
12345